Simon Dumesnil - 28 Nov 2025 Form 4 Insider Report for Pasithea Therapeutics Corp. (KTTA)

Role
Director
Signature
/s/ Simon Dumesnil
Issuer symbol
KTTA
Transactions as of
28 Nov 2025
Net transactions value
+$25,000
Form type
4
Filing time
01 Dec 2025, 08:54:08 UTC
Previous filing
27 Oct 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Dumesnil Simon Director 1111 LINCOLN ROAD, SUITE 500, MIAMI BEACH /s/ Simon Dumesnil 01 Dec 2025 0001875691

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KTTA Common Stock Purchase $25,000 +33,333 +1333% $0.7500 35,833 28 Nov 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.